INFU (InfuSystems Holdings) Total Current Assets : $35.3 Mil (As of Mar. 2025)

View and export this data going back to 1992. Start your Free Trial

What is InfuSystems Holdings Total Current Assets?

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. InfuSystems Holdings's total current assets for the quarter that ended in Mar. 2025 was $35.3 Mil.

InfuSystems Holdings Total Current Assets Historical Data

The historical data trend for InfuSystems Holdings's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InfuSystems Holdings Total Current Assets Chart

InfuSystems Holdings Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Current Assets

Get a 7-Day Free Trial

29.77

22.07

24.78

30.62

32.17

InfuSystems Holdings Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Current Assets	Get a 7-Day Free Trial															32.46	32.91	33.61	32.17	35.32

InfuSystems Holdings Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

InfuSystems Holdings's Total Current Assets for the fiscal year that ended in Dec. 2024 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	0.527	+	21.155	+	6.528	+	3.955
	=	32.2

InfuSystems Holdings's Total Current Assets for the quarter that ended in Mar. 2025 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	1.506	+	23.892	+	6.095	+	3.829
	=	35.3

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

InfuSystems Holdings (AMEX:INFU) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

InfuSystems Holdings's Liquidation Value for the quarter that ended in Mar. 2025 is

	Liquidation value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	1.506	-	49.134	+	0.75 * 23.892	+	0.5 * 6.095
=	-26.7

InfuSystems Holdings Total Current Assets Related Terms

Thank you for viewing the detailed overview of InfuSystems Holdings's Total Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

InfuSystems Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » InfuSystems Holdings Inc (AMEX:INFU) » Definitions » Total Current Assets

Comparable Companies

Traded in Other Exchanges

1TZ:Germany

Address

3851 West Hamlin Road, Rochester Hills, MI, USA, 48309

Website

http://www.infusystem.com

InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-reportable segment. The first is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second, Device Solutions, supports the Patient Services platform and leverages service orientation to win incremental business from its direct payer clients. The Device segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair. Majority from Patient.

Executives

Carrie Lachance	officer: Executive VP and COO	31700 RESEARCH PARK DRIVE, MADISON HEIGHTS MI 48071
Barry G Steele	officer: Executive VP and CFO	500 TOWN CENTER DR., SUITE 200, DEARBORN MI 48126
Richard Dilorio	officer: Executive Vice President	31700 RESEARCH PARK DRIVE, MADISON HEIGHTS MI 48071
Boyd Ralph F Jr	director
Addam Chupa	officer: Executive VP and CIO	3851 WEST HAMLIN ROAD, ROCHESTER HILLS MI 48309
Jerod Funke	officer: EVP-Chief HR Officer	3851 WEST HAMLIN RD, ROCHESTER HILLS MI 48309
Paul Andrew Gendron	director	740 BANDIT TRAIL, KELLER TX 76248
R. Rimmy Malhotra	director	C/O COMMAND CENTER, INC., 3609 S WADSWORTH BLVD., SUITE 250, LAKEWOOD CO 80235
Gregg Owen Lehman	director	309 HADDON COURT, FRANKLIN X1 37067
Christopher R. Sansone	director	C/O SANSONE ADVISORS, LLC, 151 BODMAN PLACE, SUITE 100, RED BANK NJ 07701
Kevin Whitman	officer: VP and Corporate Controller	31700 RESEARCH PARK DRIVE, MADISON HEIGHTS MI 48071
Thomas Mark Ruiz	officer: VP of Sales and Marketing	31700 RESEARCH PARK DRIVE, MADISON HEIGHTS MI 48071
Jeannine Sheehan	officer: Chief Administrative Officer	31700 RESEARCH PARK DRIVE, MADISON HEIGHTS MI 48071
Blueline Capital Partners Ii, L.p.	director	3480 BUSKIRK AVENUE, SUITE 214, PLEASANT HILL CA 94523
Meridian Tsv Ii, Lp	10 percent owner	405 WEED STREET, NEW CANAAN CT 06840